ST PHARM is a Manufacturer/Innovator, CMO/CDMO, Contract Research Organisation (CRO) company operating in the pharmaceutical industry.
ST Pharm has been offering excellent custom manufacturing services of oligonucleotides and small molecule APIs CDMO to meet clients’ high expectation for their use in pharmaceutical development in compliance to cGMP requirements. The expansion of oligonucleotide production capabilities became a new growth engine for the future pharmaceutical industry. Based on the in-depth knowledge from manufacturing nucleoside to oligonucleotide, it has enabled ST Pharm to leverage its know-how into manufacturing polynucleotide, the mRNA. STLNP(R), 5′ capping reagent (SmartCap(R)), Phosphoramidite
Company type
Manufacturer/Innovator, CMO/CDMO, Contract Research Organisation (CRO)
Products and services
Biopharmaceuticals, Custom Manufacturing
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with ST PHARM on LinkedIn
Address
ST PHARM, 7F iPark Tower, 520, Yeong-daero,, Gangnam-gu, Korea, Republic of, 6170
